Kura Oncology Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Kura Oncology Inc.

Kura Oncology Inc. | Cash Flow

No data

About Kura Oncology

View Profile

Address	3033 Science Park Road San Diego California 92121 United States
Employees	-
Website	http://www.kuraoncology.com
Updated	07/08/2019
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E.